Developing and optimizing a validated isocratic reversed-phase high-performance liquid chromatography separation of nimodipine and impurities in tablets using experimental design methodology

被引:55
作者
Barmpalexis, Panagiotis [1 ]
Kanaze, Feras Imad [2 ]
Georgarakis, Emanouil [1 ]
机构
[1] Aristotle Univ Thessaloniki, Sch Pharm, Dept Pharm & Drug Control, Thessaloniki 54124, Greece
[2] Pharmathen SA, Pharmaceut Ind, Athens, Greece
关键词
Nimodipine; Impurities; Reversed-phase HPLC; Statistical experimental design; Multiple response optimization; COMPLETE CEREBRAL-ISCHEMIA; TANDEM MASS-SPECTROMETRY; HUMAN PLASMA; BLOOD-FLOW; MIXTURE; HPLC; OPTIMIZATION; FORMULATION; SELECTIVITY; DOG;
D O I
10.1016/j.jpba.2009.03.003
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In the present study an isocratic reversed-phase high-performance liquid chromatography was investigated for the separation of nimodipine and impurities (A, B and C) using statistical experimental design. Initially, a full factorial design was used in order to screen five independent factors: type of the organic modifier - methanol or acetonitrile - and concentration, column temperature, mobile phase flow rate and pH. Except pH, the rest examined factors were identified as significant, using ANOVA analysis. The optimum conditions of separation (optimum values of significant factors) determined with the aid of central composite design were: (1) mobile phase: acetonitrile/H2O (67.5/32.5, v/v), (2) column temperature 40 degrees C and (3) mobile phase flow rate 0.9 ml/min. The proposed method showed good prediction ability (observed-predicted correlation). The analysis was found to be linear, specific, precise, sensitive and accurate. The method was also studied for robustness and intermediate precision using experimental design methodology. Three commercially available nimodipine tablets were analyzed showing good % recovery and %RSD. No traceable amounts of impurities were found in all products. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:1192 / 1202
页数:11
相关论文
共 27 条
[1]  
[Anonymous], 2005, P INT C HARM ICH Q2
[2]   High-performance liquid chromatography with ultraviolet and fluorimetric detection for the simultaneous determination of tacrine, nimodipine, and their respective metabolites in the plasma of patients with Alzheimer disease [J].
Aymard, G ;
Cayre-Castel, M ;
Fernandez, C ;
Lacomblez, L ;
Diquet, B .
THERAPEUTIC DRUG MONITORING, 1998, 20 (04) :422-429
[3]  
COHEN RJ, 1980, P 2 INT WORKSH VAS, P527
[4]   Ruggedness and robustness testing [J].
Dejaegher, Bieke ;
Vander Heyden, Yvan .
JOURNAL OF CHROMATOGRAPHY A, 2007, 1158 (1-2) :138-157
[5]   Set-up and validation of an adsorptive stripping voltammetric method for kynurenic acid determination in human urine [J].
Furlanetto, S ;
Tognini, C ;
Carpenedo, R ;
La Porta, E ;
Pinzauti, S .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 18 (1-2) :67-73
[6]   OPTIMIZATION OF SOLVENT STRENGTH AND SELECTIVITY FOR REVERSED-PHASE LIQUID-CHROMATOGRAPHY USING AN INTERACTIVE MIXTURE-DESIGN STATISTICAL TECHNIQUE [J].
GLAJCH, JL ;
KIRKLAND, JJ ;
SQUIRE, KM ;
MINOR, JM .
JOURNAL OF CHROMATOGRAPHY, 1980, 199 (OCT) :57-79
[7]  
HOFFMEISTER F, 1982, ARZNEIMITTEL-FORSCH, V32-1, P347
[8]  
KAZDA S, 1982, ARZNEIMITTEL-FORSCH, V32-1, P331
[9]  
KAZDA S, 1983, J CEREB BLOOD FLOW M, V3, P526
[10]   High-performance liquid chromatography with amperometric detection applied to the screening of 1,4-dihydropyridines in human plasma [J].
López, JA ;
Martínez, V ;
Alonso, RM ;
Jiménez, RM .
JOURNAL OF CHROMATOGRAPHY A, 2000, 870 (1-2) :105-114